Comparison of acrylamide metabolism in humans and rodents

Advances in Experimental Medicine and Biology

Volumn 561, Issue , 2005, Pages 109-116

  Fennell, Timothy R ^a   Friedman, Marvin A ^b  

^a RTI INTERNATIONAL   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Acrylamide; Glycidamide; Metabolism

Indexed keywords

ACRYLAMIDE; GLUTATHIONE; GLYCIDAMIDE; DEUTERIUM OXIDE; EPOXIDE; OXYGEN;

ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; HUMAN; MALE; MALE STERILITY; METABOLISM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; URINALYSIS; ANIMAL; CHEMICAL MODEL; CHEMISTRY; COMPARATIVE STUDY; DOSE RESPONSE; HYDROLYSIS; MOUSE; RAT; SPECIES DIFFERENCE; TIME;

RODENTIA;

ACRYLAMIDE; ANIMALS; DEUTERIUM OXIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPOXY COMPOUNDS; GLUTATHIONE; HUMANS; HYDROLYSIS; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MODELS, CHEMICAL; OXYGEN; RATS; SPECIES SPECIFICITY; TIME FACTORS;

EID: 33644855990     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/0-387-24980-X_9     Document Type: Article

References (15)

1. Calleman, C. J., Bergmark, E., and Costa, L. G., 1990, Acrylamide is metabolized to glycidamide in the rat: evidence from hemoglobin adduct formation, Chem Res Toxicol 3:406-412.
2. Calleman, C. J., Stern, L. G., Bergmark, E., and Costa, L. G., 1992, Linear versus nonlinear models for hemoglobin adduct formation by acrylamide and its metabolite glycidamide: implications for risk estimation, Cancer Epidemiol Biomarkers Prev 1:361-368.
3. Dearfield, K. L., Abernathy, C. O., Ottley, M. S., Brantner, J. H., and Hayes, P. F., 1988, Acrylamide: its metabolism, developmental and reproductive effects, genotoxicity, and carcinogenicity, Mutat Res 195:45-77.
4. Dearfield, K. L., Douglas, G. R., Ehling, U. H., Moore, M. M., Sega, G. A., and Brusick, D. J., 1995, Acrylamide: a review of its genotoxicity and an assessment of heritable genetic risk, Mutat Res 330:71-99.
5. Dixit, R., Seth, P. K., and Mukjtar, H., 1982, Metabolism of acrylamide into urinary mercapturic acid and cysteine conjugates in rats, Drug Metab Dispos 10:196-197.
6. Edwards, P. M., 1975, The distribution and metabolism of acrylamide and its neurotoxic analogues in rats, Biochem Pharmacol 24:1277-1282.
7. European Union, 2002, European Union Risk Assessment Report Acrylamide, Luxembourg, pp. 210 pp.
8. Fennell, T. R., Sumner, S. C., Snyder, R. W., Burgess, J., Spicer, R., Bridson, W. E., and Friedman, M. A., 2004, Metabolism and Hemoglobin Adduct Formation of Acrylamide in Humans, Tox. Sci. submitted.
9. IARC, 1994, Acrylamide, IARC Monogr Eval Carcinog Risks Hum 60:389-433.
10. Miller, M. J., Carter, D. E., and Sipes, I. G., 1982, Pharmacokinetics of acrylamide in Fisher-344 rats, Toxicol Appl Pharmacol 63:36-44.
11. Sorgel, F., Weissenbacher, R., Kinzig-Schippers, M., Hofmann, A., Illauer, M., Skott, A., and Landersdorfer, C., 2002, Acrylamide: increased concentrations in homemade food and first evidence of its variable absorption from food, variable metabolism and placental and breast milk transfer in humans, Chemotherapy 48:267-274.
12. Spencer, P. S., and Schaumburg, H. H., 1974a, A review of acrylamide neurotoxicity. Part I. Properties, uses and human exposure, Can J Neural Sci 1:143-150.
13. Spencer, P. S., and Schaumburg, H. H., 1974b, A review of acrylamide neurotoxicity. Part II. Experimental animal neurotoxicity and pathologic mechanisms, Can J Neurol Sci 1:152-169.
14. Spencer, P. S., and Schaumburg, H. H., 1975, Nervous system degeneration produced by acrylamide monomer, Environ Health Perspect 11:129-133.
15. 13C nuclear magnetic resonance spectroscopy, Chem Res Toxicol 5:81-89.